Global Cell Culture Products Market, Product (Consumables, Equipment), Cell Culture Application (Biopharmaceutical/Therapeutics, Stem Cell Technology, Cancer Research, Drug Screening and Development, Tissue Engineering and Regenerative Medicine, Others), End- Users (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research Institutes, Cell Banks) - Industry Trends and Forecast to 2030.
Cell Culture Products Market Analysis and Size
Cell culture grows the cell under certain controlled conditions outside its natural environment. Once the cells of interest have been isolated from living tissue, they can be maintained under carefully controlled conditions. Recent developments in gene expression technologies have enabled the production of novel vaccines and biopharmaceuticals, thereby increasing the research & development applications of cell culture techniques. Moreover, a rise in cancer research projects and a broadening scope of applications for gene therapies are expected to drive the market.
Data Bridge Market Research analyses that the cell culture products market, which was USD 2,500.00 million in 2022, would rocket up to USD 7,000.00 million by 2030, and is expected to undergo a CAGR of 12.00% during the forecast period. This indicates the market value. Consumables dominates the product segment of the Cell Culture Products market owing to the growing demand for cell culture media. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cell Culture Products Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015-2020)
Revenue in USD Million, Volumes in Units, and Pricing in USD
Product (Consumables, Equipment), Cell Culture Application (Biopharmaceutical/Therapeutics, Stem Cell Technology, Cancer Research, Drug Screening and Development, Tissue Engineering and Regenerative Medicine, Others), End- Users (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research Institutes, Cell Banks)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), HiMedia Laboratories (India), Avantor, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Sartorius AG (Germany), Corning Incorporated (U.S.), Lonza Group Ltd. (Switzerland), Evonik (Germany),and Cell Rev (U.K) among others
Cell biology warrants in-depth research into its various facets, such as stem cell and gene therapy. Manufacturers must invest in high-quality equipment and other inputs to develop high-end products that adhere to high regulatory standards. This limits the accessibility of smaller enterprises to the priced cell culture resources. The same applies to research institutes with limited capacities. Even further in the processing steps, manufacturers must invest time and technical expertise for cell harvesting.
Global Cell Culture Products Market Dynamics
- Rising Preference for Cell-based Vaccines Surges Product Demand
The threat of virus outbreaks has created a lucrative market for vaccines globally. However, this has also led to the demand for highly efficient vaccine variants. Hence, the pharm industry has adopted cell culture extensively for developing vaccines. Cell culture finds application in developing various vaccines for rotavirus, polio, rubella, hepatitis, and chickenpox. Developed nations are significantly developing a penchant for cell-based vaccines. This has eased regulatory processes of cell-based vaccine approval in these regions. Moreover, there is growing awareness about the many benefits of cell culture vaccines.
- Research and development proficiencies
Rising expenditure for research and development proficiencies, especially in developed and developing economies about medical drugs will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments are also expected to drive the market growth rate.
- Cutting-edge Solutions for Treatment Bolster Market Prospects
The cell culture market is currently expanding due to innovations. Various biotech and pharmaceutical companies are investing heavily in cell culture research and development. Hence, the demand for advanced cell culture product variants is rising. Similarly, there is an increasing need for novel therapeutics like biosimilars that positively impact market prospects.
Furthermore, an upsurge in the public-private funding for target research activities, rising demand for chronic diseases treatments using advanced drugs, and rising product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the rising internet penetration rate, increasing adoption of cell media, rise in healthcare products globally, and increasing per capita expenditure on healthcare will further expand the market's growth rate.
On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, high costs associated with medicine, and a shortage of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This Cell Culture Products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Cell Culture Products market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
- In June 2022, Evonik launched the cQrex portfolio of cell culture ingredients to increase efficiency and productivity in bioprocesses for producing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells
- In February 2022, CellulaREvolution raised GBP 1.75 million to accelerate the launch of its continuous cell culture technology
Global Cell Culture Products Market Scope
The cell culture products market is segmented on the basis of product type, cell culture application application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Cell Culture Application
- Stem Cell Technology
- Cancer Research
- Drug Screening and Development
- Tissue Engineering
- Regenerative Medicine
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Cell Banks
Global Cell Culture Products Market Regional Analysis/Insights
The global cell culture products market is analysed and market size insights and trends are provided by country, type, price range, application, and end- user as referenced above.
The countries covered in the cell culture products market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the cell culture products market because of the strong base of healthcare facilities, the strong presence of major players in the market, increased cases of chronic disease, and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Cell Culture Products market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Cell Culture Products market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Cell Culture Products market. The data is available for the historic period 2015-2020.
Competitive Landscape and Cell Culture Products Market Share Analysis
The Cell Culture Products market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the cell culture products market are:
- Thermo Fisher Scientific Inc. (U.S.)
- Merck KGaA (Germany)
- HiMedia Laboratories (India)
- Avantor, Inc. (U.S.)
- FUJIFILM Holdings Corporation (Japan)
- Agilent Technologies, Inc. (U.S.)
- Sartorius AG (Germany)
- Corning Incorporated (U.S.)
- Lonza Group Ltd. (Switzerland)
- Evonik (Germany)
- Cell Rev (U.K)